Loading…
IntegraDose Compounding Services LLC, a drug compounding company, received an FDA Warning Letter on May 6, 2020, indicating compliance issues with federal pharmaceutical regulations. Due to the limited metadata available, the specific nature of the violations cannot be determined from this record alone. The letter falls under FDA's drug product oversight, though the issuing office and detailed violation categories are not specified in the available information. A review of the complete Warning Letter would be necessary to identify the specific compounding practices or quality control deficiencies that prompted the agency's enforcement action.